04/08/2024 4:09 PM | Paradigm Biocapital Advisors LP (Filed by) Y-mAbs Therapeutics (Subject)
| Form SC 13G | |
03/14/2024 4:01 PM | TAGLIAFERRI MARY (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 8:17 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 5:17 AM | TAGLIAFERRI MARY (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/07/2024 4:02 PM | Rajah Vignesh (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:49 PM | Smith Susan Laura (Reporting) Y-mAbs Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 3:40 PM | Rajah Vignesh (Reporting) Y-mAbs Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/05/2024 6:05 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 5:05 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 4:04 PM | Y-mAbs Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/06/2024 2:59 PM | ACORN BIOVENTURES, L.P. (Filed by) Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024 4:54 PM | Lund-Hansen Torben (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 4:56 PM | Wilms Joris (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 4:58 PM | Lisby Steen (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 5:00 PM | Smith Susan Laura (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 5:02 PM | Rajah Vignesh (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 4:48 PM | Kruse Bo (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 4:52 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 5:45 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 3:15 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 6:40 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 3:40 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 7:27 AM | WG Biotech ApS (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:26 AM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 4:25 PM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 4:25 PM | WG Biotech ApS (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 4:14 PM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 4:15 PM | WG Biotech ApS (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 4:14 PM | WG Biotech ApS (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 4:15 PM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 3:47 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 4:15 PM | Rossi Michael J (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/08/2023 4:16 PM | Rossi Michael J (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 4:19 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 3:09 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 8:00 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/09/2023 5:00 PM | TYAGI ASHU (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:00 PM | HEALY JAMES (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:01 PM | GILL DAVID N (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:02 PM | Ber Gerard (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:04 PM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
06/09/2023 5:05 PM | Hamill Laura (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 4:30 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2023 8:41 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2023 11:15 PM | Y-mAbs Therapeutics (Filer)
| Form EFFECT | |
04/28/2023 5:08 AM | Y-mAbs Therapeutics (Filer)
| Form DEF 14A | |
04/28/2023 5:09 AM | Y-mAbs Therapeutics (Filer)
| Form DEFA14A | |
04/28/2023 5:11 AM | Y-mAbs Therapeutics (Filer)
| Form ARS | |